Flexible ureterorenoscopy or extracorporeal shockwave lithotripsy in stone disease and bevacizumab for hereditary and sporadic papillary renal‐cell cancer

Ähnliche Einträge

• Precision by recognition: smarter firing for better lithotripsy
  von: Arkadiusz Miernik, et al.
  Veröffentlicht: (2026)
• The impact of kidney stone disease on quality of life in high‐risk stone formers
  von: Anis Assad, et al.
  Veröffentlicht: (2024)
• Awareness and perspectives on hereditary renal cell carcinoma and genetic testing in clinical practice: a multi‐national survey
  von: Chiara Re, et al.
  Veröffentlicht: (2025)
• The perioperative outcomes of papillary versus non‐papillary access in percutaneous nephrolithotomy
  von: Mohammed Lotfi Amer, et al.
  Veröffentlicht: (2025)
• Serial manual bolus irrigation leads to critical intrarenal pressures during flexible ureterorenoscopy – time to abandon this manoeuvre
  von: Anne Hong, et al.
  Veröffentlicht: (2024)